LD-2 disclosure · 4th Quarter - Report
RANBAXY INC.
Client
- Name
- RANBAXY INC.
- Description
- Pharmaceuticals
- Location
- New Jersey · United States of America
Registrant
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
S.369/HR 1706, Preserve Acess to Affordable Generics; HR 759, FDA Globalization Act; S.3690, Drug Safety & Accountability Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S.3677, the Financial Services & General Government Appropriations Act; HR3082, Continuing Appropriations & Surface Transportation Act.
Lobbyistsmr MATTHEW TODD TUTEN · ANURAG VARMA · JOHN JONAS · ERIC RASMUSSEN
Covered position (mr MATTHEW TODD TUTEN): RepMichaelBilirakis91-92;93-95;98-01
Covered position (ERIC RASMUSSEN): SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
S.369/HR 1706, Preserve Acess to Affordable Generics; HR 759, FDA Globalization Act; S.3690, Drug Safety & Accountability Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S.3677, the Financial Services & General Government Appropriations Act; HR3082, Continuing Appropriations & Surface Transportation Act.
Lobbyistsmr MATTHEW TODD TUTEN · ANURAG VARMA · JOHN JONAS · ERIC RASMUSSEN
Covered position (mr MATTHEW TODD TUTEN): RepMichaelBilirakis91-92;93-95;98-01
Covered position (ERIC RASMUSSEN): SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000